Tim-3 expression is increased in T cells infiltrating chronic HBV infection, and the Tim-3/galectin-9 pathway is associated with poor prognosis in patients with HBV-associated HCC [160]. The gene discussed is HAVCR2; the disease is hepatocellular carcinoma.